Name
Session 14: Practice Changing Papers
Date & Time
Saturday, May 3, 2025, 2:10 PM - 3:00 PM
Speakers
Axel Bex, The Netherlands Cancer Institute, Amsterdam
Guillermo de Velasco, Hospital 12 de Octubre
Koen van der Mijn, The Netherlands Cancer Institute
Michael Staehler, Ludwig-Maximilians University of Munich
Manuela Schmidinger, Department of Urology, Medical University of Vienn
Tian Zhang, UTSW
Scott Shepherd, The Royal Marsden NHS Foundation Trust
Sofie Wilgenhof, Antoni Van Leeuwenhoek Hospital
Guillermo de Velasco, Hospital 12 de Octubre
Koen van der Mijn, The Netherlands Cancer Institute
Michael Staehler, Ludwig-Maximilians University of Munich
Manuela Schmidinger, Department of Urology, Medical University of Vienn
Tian Zhang, UTSW
Scott Shepherd, The Royal Marsden NHS Foundation Trust
Sofie Wilgenhof, Antoni Van Leeuwenhoek Hospital






Description
Chairs: Manuela Schmidinger, MD and Michael Staehler, MD, PhD
Paper 1: Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study: Scott Shepherd
Discussant for Paper 1: Belzutifan: Guillermo De Velasco, MD, PhD
Paper 2: Neoadjuvant Toripalimab Plus Axitinib for Clear Cell Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus: NEOTAX, a Phase 2 Study: Koen van der Mijn
Discussant for Paper 2: Toripalimab: Axel Bex, MD, PhD
Paper: Sunniforecast: Sofie Wilgenhof
Discussant for Paper 3: Tian Zhang, MD, MHS
Moderated Q&A: Manuela Schmidinger, MD and Michael Staehler, MD, PhD
Location Name
Grote Zaal
Full Address
Beurs van Berlage
Damrak 243
Amsterdam-Centrum
Amsterdam NH 1012 ZJ
Netherlands
Damrak 243
Amsterdam-Centrum
Amsterdam NH 1012 ZJ
Netherlands